Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1060812-84-1

Post Buying Request

1060812-84-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1060812-84-1 Usage

General Description

5-Bromopyrazolo[1,5-a]pyridine is a chemical compound with the molecular formula C7H4BrN3. It is a pyridine derivative that contains a bromine atom and a pyrazole ring. 5-Bromopyrazolo[1,5-a]pyridine has been studied for its potential use in various applications, including as a building block in organic synthesis for the production of pharmaceuticals and agrochemicals. It has also been investigated for its potential biological activities, such as its inhibitory effects on certain enzymes. Additionally, 5-Bromopyrazolo[1,5-a]pyridine has been explored for its use in the development of new materials and functional molecules. Due to its unique structure and potential utility, this compound continues to be of interest to researchers in the chemical and pharmaceutical industries.

Check Digit Verification of cas no

The CAS Registry Mumber 1060812-84-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,6,0,8,1 and 2 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1060812-84:
(9*1)+(8*0)+(7*6)+(6*0)+(5*8)+(4*1)+(3*2)+(2*8)+(1*4)=121
121 % 10 = 1
So 1060812-84-1 is a valid CAS Registry Number.

1060812-84-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Bromopyrazolo[1,5-a]pyridine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1060812-84-1 SDS

1060812-84-1Synthetic route

ethyl 5-bromopyrazolo[1,5-a]pyridine-3-carboxylate
885276-93-7

ethyl 5-bromopyrazolo[1,5-a]pyridine-3-carboxylate

5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

Conditions
ConditionsYield
With sulfuric acid at 100℃; for 4h;99.5%
Stage #1: ethyl 5-bromopyrazolo[1,5-a]pyridine-3-carboxylate With sulfuric acid; water for 18h; Reflux;
Stage #2: With sodium hydroxide In water pH=7;
96%
With sulfuric acid In water at 110℃; for 16h;60%
5-((tert-butoxycarbonyl)amino)pyrazolo[1,5-a]pyridine-3-carboxylic acid ethyl ester
1101120-33-5

5-((tert-butoxycarbonyl)amino)pyrazolo[1,5-a]pyridine-3-carboxylic acid ethyl ester

5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: dichloromethane / 18 h / 20 °C
2.1: hydrogen bromide; sodium nitrite / water / 0.25 h / 0 °C
2.2: 0.25 h / 50 °C
2.3: pH 5
3.1: sulfuric acid; water / 18 h / Reflux
3.2: pH 7
View Scheme
ethyl 5-aminopyrazolo[1,5-a]pyridine-3-carboxylate trifluoroacetate

ethyl 5-aminopyrazolo[1,5-a]pyridine-3-carboxylate trifluoroacetate

5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: hydrogen bromide; sodium nitrite / water / 0.25 h / 0 °C
1.2: 0.25 h / 50 °C
1.3: pH 5
2.1: sulfuric acid; water / 18 h / Reflux
2.2: pH 7
View Scheme
N-(4-pyridyl) t-butyl carbamate
98400-69-2

N-(4-pyridyl) t-butyl carbamate

5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: O-(2,4-dinitrophenyl)hydroxylamine / acetonitrile / 18 h / 40 °C
1.2: 18 h / 20 °C
2.1: dichloromethane / 18 h / 20 °C
3.1: hydrogen bromide; sodium nitrite / water / 0.25 h / 0 °C
3.2: 0.25 h / 50 °C
3.3: pH 5
4.1: sulfuric acid; water / 18 h / Reflux
4.2: pH 7
View Scheme
1-amino-4-bromopyridin-1-ium iodide
1533440-88-8

1-amino-4-bromopyridin-1-ium iodide

5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium carbonate / N,N-dimethyl-formamide / 0.17 h
2: sulfuric acid / 80 °C
View Scheme
Multi-step reaction with 2 steps
1: potassium carbonate / N,N-dimethyl-formamide / 20 °C
2: sulfuric acid / 80 °C
View Scheme
4-bromopyridin
1120-87-2

4-bromopyridin

5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: mesitylenesulfonylhydroxylamine / N,N-dimethyl-formamide / 16 h / 0 - 40 °C
1.2: 6 h / 0 - 20 °C
2.1: sulfuric acid / water / 16 h / 110 °C
View Scheme
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

Vilsmeier reagent
3724-43-4, 149409-22-3

Vilsmeier reagent

5-bromopyrazolo[1,5-a]pyridine-3-carbaldehyde
1101120-53-9

5-bromopyrazolo[1,5-a]pyridine-3-carbaldehyde

Conditions
ConditionsYield
In dichloromethane at 44℃;100%
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

5-bromo-3-iodopyrazolo[1,5-a]pyridine
1352881-82-3

5-bromo-3-iodopyrazolo[1,5-a]pyridine

Conditions
ConditionsYield
With N-iodo-succinimide In methanol at -10 - 20℃; for 18.5h;97.5%
With N-iodo-succinimide In acetonitrile at 20℃; for 16h;96%
With N-iodo-succinimide In acetonitrile at 20℃; for 1h;89%
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

5-bromopyrazolo[1,5-a]pyridine-3-carbaldehyde
1101120-53-9

5-bromopyrazolo[1,5-a]pyridine-3-carbaldehyde

Conditions
ConditionsYield
Stage #1: 5-bromopyrazolo[1,5-a]pyridine; N,N-dimethyl-formamide With trichlorophosphate at 20℃; for 2h; Vilsmeier formylation; Inert atmosphere;
Stage #2: With sodium hydroxide In water pH=10;
96%
2-methoxy-4-trifluoromethoxybenzeneboronic acid
355836-10-1

2-methoxy-4-trifluoromethoxybenzeneboronic acid

5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

5-[2-methoxy-4-(trifluoromethoxy)phenyl]pyrazolo[1,5-a]pyridine

5-[2-methoxy-4-(trifluoromethoxy)phenyl]pyrazolo[1,5-a]pyridine

Conditions
ConditionsYield
With potassium phosphate; bis[tris( 1,1-dimethylethyl)phosphine]-palladium In 1,4-dioxane; water at 80℃; for 16h;85%
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

3-(methanesulfonyl)phenylboronic acid
373384-18-0

3-(methanesulfonyl)phenylboronic acid

5-(3-(methylsulfonyl)phenyl)pyrazolo[1,5-a]pyridine

5-(3-(methylsulfonyl)phenyl)pyrazolo[1,5-a]pyridine

Conditions
ConditionsYield
With bis-triphenylphosphine-palladium(II) chloride; potassium carbonate In water; N,N-dimethyl-formamide at 90℃; for 12h; Suzuki Coupling; Inert atmosphere;77%
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarbonitrile
1206641-31-7

1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarbonitrile

1-(4-pyrazolo[1,5-a]pyridin-5-ylphenyl)cyclopropanecarbonitrile

1-(4-pyrazolo[1,5-a]pyridin-5-ylphenyl)cyclopropanecarbonitrile

Conditions
ConditionsYield
With potassium phosphate; bis[tris( 1,1-dimethylethyl)phosphine]-palladium In 1,4-dioxane; water at 80℃; for 16h;76%
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

3-(cyclopropylsulfonyl)phenylboronic acid
1020204-12-9

3-(cyclopropylsulfonyl)phenylboronic acid

5-(3-(cyclopropylsulfonyl)phenyl)pyrazolo[1,5-a]pyridine

5-(3-(cyclopropylsulfonyl)phenyl)pyrazolo[1,5-a]pyridine

Conditions
ConditionsYield
With bis-triphenylphosphine-palladium(II) chloride; potassium carbonate In water; N,N-dimethyl-formamide at 90℃; for 12h; Suzuki Coupling; Inert atmosphere;75%
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

bis(pinacol)diborane
73183-34-3

bis(pinacol)diborane

5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-a]pyridine

5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-a]pyridine

Conditions
ConditionsYield
With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 110℃; for 8h; Inert atmosphere;75%
With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; potassium acetate In 1,4-dioxane at 105 - 110℃; for 1.5h;
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

N-(2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)-2,4-difluorobenzenesulfonamide
1083326-73-1

N-(2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)-2,4-difluorobenzenesulfonamide

2,4-difluoro-N-(2-methoxy-5-(pyrazolo[1,5-a]pyridin-5-yl)pyridin-3-yl)benzenesulfonamide
1621718-79-3

2,4-difluoro-N-(2-methoxy-5-(pyrazolo[1,5-a]pyridin-5-yl)pyridin-3-yl)benzenesulfonamide

Conditions
ConditionsYield
With bis-triphenylphosphine-palladium(II) chloride; sodium carbonate In 1,4-dioxane; water at 90℃; Inert atmosphere;73%
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

Cyclopropylamine
765-30-0

Cyclopropylamine

N-cyclopropylpyrazolo[1,5-a]pyridin-5-amine
1610612-76-4

N-cyclopropylpyrazolo[1,5-a]pyridin-5-amine

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl; sodium t-butanolate In toluene at 90℃; for 2h; Inert atmosphere; Microwave irradiation;62%
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

2-[4-(1-methoxy-1-methyl-ethyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-[4-(1-methoxy-1-methyl-ethyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

5-[4-(1-methoxy-1-methyl-ethyl)phenyl]pyrazolo[1,5-a]pyridine

5-[4-(1-methoxy-1-methyl-ethyl)phenyl]pyrazolo[1,5-a]pyridine

Conditions
ConditionsYield
With potassium phosphate; bis[tris( 1,1-dimethylethyl)phosphine]-palladium In 1,4-dioxane; water at 80℃; for 16h;59%
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(2,2,2-trifluoroethoxy)pyridine

5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(2,2,2-trifluoroethoxy)pyridine

5-[6-(2,2,2-trifluoroethoxy)-3-pyridyl]pyrazolo[1,5-a]pyridine

5-[6-(2,2,2-trifluoroethoxy)-3-pyridyl]pyrazolo[1,5-a]pyridine

Conditions
ConditionsYield
With potassium phosphate; bis[tris( 1,1-dimethylethyl)phosphine]-palladium In 1,4-dioxane; water at 80℃; for 16h;53%
t-butyl bromide
507-19-7

t-butyl bromide

5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

5-bromo-3-tert-butylpyrazolo[1,5-a]pyridine

5-bromo-3-tert-butylpyrazolo[1,5-a]pyridine

Conditions
ConditionsYield
Stage #1: t-butyl bromide With aluminum (III) chloride In dichloromethane at 0℃; for 0.166667h; Inert atmosphere;
Stage #2: 5-bromopyrazolo[1,5-a]pyridine In dichloromethane at 0℃; for 3h; Inert atmosphere;
46%
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyrimidine

2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyrimidine

2-(6-methylpyridin-2-yl)-3-(pyrazolo[1,5-a]pyridine-5-yl)imidazo[1,2-a]pyrimidine

2-(6-methylpyridin-2-yl)-3-(pyrazolo[1,5-a]pyridine-5-yl)imidazo[1,2-a]pyrimidine

Conditions
ConditionsYield
With palladium diacetate; caesium carbonate; triphenylphosphine In 1,4-dioxane at 120℃;38%
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

C13H14N2OSi

C13H14N2OSi

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: trichlorophosphate / 2 h / 20 °C / Inert atmosphere
1.2: pH 10
2.1: copper(l) iodide; bis-triphenylphosphine-palladium(II) chloride; triethylamine / N,N-dimethyl-formamide / 2 h / 60 °C / Inert atmosphere
View Scheme
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

C9H9BrN4

C9H9BrN4

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: trichlorophosphate / 2 h / 20 °C / Inert atmosphere
1.2: pH 10
2.1: sodium hydrogencarbonate / methanol
View Scheme
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

C12H14N4

C12H14N4

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: trichlorophosphate / 2 h / 20 °C / Inert atmosphere
1.2: pH 10
2.1: tetrakis(triphenylphosphine) palladium(0) / toluene / 18 h / Inert atmosphere; Reflux
3.1: sodium hydrogencarbonate / methanol
View Scheme
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

C11H12N4

C11H12N4

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: trichlorophosphate / 2 h / 20 °C / Inert atmosphere
1.2: pH 10
2.1: tetrakis(triphenylphosphine) palladium(0) / toluene / 2 h / Inert atmosphere; Reflux
3.1: sodium hydrogencarbonate / methanol
View Scheme
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

C11H10N4

C11H10N4

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: trichlorophosphate / 2 h / 20 °C / Inert atmosphere
1.2: pH 10
2.1: copper(l) iodide; bis-triphenylphosphine-palladium(II) chloride; triethylamine / N,N-dimethyl-formamide / 2 h / 60 °C / Inert atmosphere
3.1: methanol; potassium carbonate / 2 h
4.1: sodium hydrogencarbonate / methanol
View Scheme
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

5-cyclopropylpyrazolo[1,5-a]pyridine-3-carbaldehyde
1101120-63-1

5-cyclopropylpyrazolo[1,5-a]pyridine-3-carbaldehyde

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: trichlorophosphate / 2 h / 20 °C / Inert atmosphere
1.2: pH 10
2.1: tetrakis(triphenylphosphine) palladium(0) / toluene / 18 h / Inert atmosphere; Reflux
View Scheme
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

5-vinylpyrazolo[1,5-a]pyridine-3-carbaldehyde
1101120-61-9

5-vinylpyrazolo[1,5-a]pyridine-3-carbaldehyde

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: trichlorophosphate / 2 h / 20 °C / Inert atmosphere
1.2: pH 10
2.1: tetrakis(triphenylphosphine) palladium(0) / toluene / 2 h / Inert atmosphere; Reflux
View Scheme
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

5-ethynylpyrazolo[1,5-a]pyridine-3-carbaldehyde
1101120-65-3

5-ethynylpyrazolo[1,5-a]pyridine-3-carbaldehyde

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: trichlorophosphate / 2 h / 20 °C / Inert atmosphere
1.2: pH 10
2.1: copper(l) iodide; bis-triphenylphosphine-palladium(II) chloride; triethylamine / N,N-dimethyl-formamide / 2 h / 60 °C / Inert atmosphere
3.1: methanol; potassium carbonate / 2 h
View Scheme
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

N'-((5-bromopyrazolo[1,5-a]pyridin-3-yl)methylene)-N,2-dimethyl-5-nitrobenzenesulfonohydrazide
1101118-18-6

N'-((5-bromopyrazolo[1,5-a]pyridin-3-yl)methylene)-N,2-dimethyl-5-nitrobenzenesulfonohydrazide

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: trichlorophosphate / 2 h / 20 °C / Inert atmosphere
1.2: pH 10
2.1: sodium hydrogencarbonate / methanol
3.1: sodium hydrogencarbonate / methanol / 0.5 h
View Scheme
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

N'-((5-cyclopropylpyrazolo[1,5-a]pyridin-3-yl)methylene)-N,2-dimethyl-5-nitrobenzenesulfonohydrazide
1101118-21-1

N'-((5-cyclopropylpyrazolo[1,5-a]pyridin-3-yl)methylene)-N,2-dimethyl-5-nitrobenzenesulfonohydrazide

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: trichlorophosphate / 2 h / 20 °C / Inert atmosphere
1.2: pH 10
2.1: tetrakis(triphenylphosphine) palladium(0) / toluene / 18 h / Inert atmosphere; Reflux
3.1: sodium hydrogencarbonate / methanol
4.1: sodium hydrogencarbonate / methanol / 0.5 h
View Scheme
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

N,2-dimethyl-5-nitro-N'-((5-vinylpyrazolo[1,5-a]pyridin-3-yl)methylene)benzenesulfonohydrazide
1101118-20-0

N,2-dimethyl-5-nitro-N'-((5-vinylpyrazolo[1,5-a]pyridin-3-yl)methylene)benzenesulfonohydrazide

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: trichlorophosphate / 2 h / 20 °C / Inert atmosphere
1.2: pH 10
2.1: tetrakis(triphenylphosphine) palladium(0) / toluene / 2 h / Inert atmosphere; Reflux
3.1: sodium hydrogencarbonate / methanol
4.1: sodium hydrogencarbonate / methanol / 0.5 h
View Scheme
5-bromopyrazolo[1,5-a]pyridine
1060812-84-1

5-bromopyrazolo[1,5-a]pyridine

N'-((5-ethynylpyrazolo[1,5-a]pyridin-3-yl)methylene)-N,2-dimethyl-5-nitrobenzenesulfonohydrazide
1101118-22-2

N'-((5-ethynylpyrazolo[1,5-a]pyridin-3-yl)methylene)-N,2-dimethyl-5-nitrobenzenesulfonohydrazide

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: trichlorophosphate / 2 h / 20 °C / Inert atmosphere
1.2: pH 10
2.1: copper(l) iodide; bis-triphenylphosphine-palladium(II) chloride; triethylamine / N,N-dimethyl-formamide / 2 h / 60 °C / Inert atmosphere
3.1: methanol; potassium carbonate / 2 h
4.1: sodium hydrogencarbonate / methanol
5.1: sodium hydrogencarbonate / methanol / 0.5 h
View Scheme

1060812-84-1Relevant articles and documents

Efficient salt-induced kinase inhibitor and preparation method thereof

-

Paragraph 0041-0044, (2021/09/04)

The invention discloses an efficient salt-induced kinase inhibitor and a preparation method thereof, and the efficient salt-induced kinase inhibitor is characterized by comprising substances of a chemical formula in the invention. The salt-induced kinase inhibitor with excellent performance has high inhibitory activity for in-vitro experiments and also has high cell inhibitory activity.

HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS AND COMBINATIONS THEREOF

-

, (2015/07/07)

Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by disregulation of a fatty acid synthase pathway by the administration of such compounds and combinations of such compounds and other therapeutic agents.

HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS

-

, (2014/01/18)

Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by disregulation of a fatty acid synthase pathway by the administration of such compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1060812-84-1